InfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024

Rhea-AI Summary

InfuSystem Holdings, Inc. (INFU) will release its preliminary fourth quarter and full year 2023 financial results on March 14, 2024, before the market opens. A conference call will be held at 9:00 a.m. Eastern Time on the same day to discuss the results.

Investor Conference Call to be held 9:00 a.m. Eastern Time

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)-- InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue preliminary fourth quarter and full year 2023 financial results on Thursday, March 14, 2024, before the market opens.

The Company will also conduct a conference call for all interested parties on Thursday, March 14, 2024 at 9:00 a.m. Eastern Time to discuss its financial results.

To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the Investors section of the Company’s website at https://ir.infusystem.com/. A replay of the call will be available by visiting https://ir.infusystem.com/ for the next 90 days or by calling (877) 344-7529 or (412) 317-0088, replay access code 2665790 through Thursday, March 21, 2024.

About InfuSystem Holdings, Inc.

InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient Services segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240308786472/en/

Joe Dorame, Joe Diaz & Robert Blum

Lytham Partners, LLC

602-889-9700

Source: InfuSystem Holdings, Inc.

FAQ

When will InfuSystem Holdings, Inc. release its preliminary fourth quarter and full year 2023 financial results?

InfuSystem Holdings, Inc. will release its preliminary fourth quarter and full year 2023 financial results on March 14, 2024, before the market opens.

What time will the conference call to discuss InfuSystem Holdings, Inc.'s financial results be held on March 14, 2024?

The conference call to discuss InfuSystem Holdings, Inc.'s financial results will be held at 9:00 a.m. Eastern Time on March 14, 2024.

How can interested parties participate in the conference call?

Interested parties can participate in the conference call by dialing (833) 366-1127 or (412) 902-6773, or by listening via a live webcast available on the Investors section of the Company’s website at https://ir.infusystem.com/.

Will there be a replay of the conference call available?

Yes, a replay of the conference call will be available by visiting https://ir.infusystem.com/ for the next 90 days or by calling (877) 344-7529 or (412) 317-0088, replay access code 2665790 through Thursday, March 21, 2024.